PALISADE BIO, INC. Proceeds from Long-Term Debt Issued
PALISADE BIO, INC. (PALI) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2016-03-14
- PALISADE BIO, INC. proceeds from issuance of long-term debt for the quarter ending 2014-12-31 was $4.21M.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for the quarter ending 2014-09-30 was $0.00.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for the quarter ending 2014-06-30 was $0.00.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for fiscal 2014 was $4.21M, a 44.21% decline from fiscal 2013.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for fiscal 2013 was $7.55M.
- PALISADE BIO, INC. proceeds from issuance of long-term debt for fiscal 2012 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-14 | |||
| 2014-12-31 | $4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $4.21M derived: sum of 2 quarters · filed 2016-03-14 | $4.21M derived: sum of 3 quarters · filed 2016-03-14 | $4.21M 10-K · filed 2016-03-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | $0.00 derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | $0.00 derived: sum of 3 quarters · filed 2016-03-14 | $0.00 derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $0.00 derived: sum of 3 quarters · filed 2016-03-14 | $0.00 derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $0.00 derived: sum of 3 quarters · filed 2016-03-14 | $7.55M 10-K · filed 2016-03-14 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $7.55M 10-Q · filed 2014-11-07 | $7.55M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $7.55M 10-Q · filed 2014-08-08 | $7.55M derived: sum of 3 quarters · filed 2015-03-16 | $7.55M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $7.55M 10-Q · filed 2014-05-12 | $7.55M derived: sum of 2 quarters · filed 2015-03-16 | $7.55M derived: sum of 3 quarters · filed 2015-03-16 | $7.55M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |